Your browser doesn't support javascript.
loading
[Research progress of influenza vaccination, pneumococcal vaccination and COVID-19 vaccination among cancer patients].
Sui, H T; Guo, Y; Yang, Z N; Su, J F; Shu, X; Zhang, Y; Yang, X M.
Afiliação
  • Sui HT; China National Biotec Group, Beijing 100029, China.
  • Guo Y; China National Biotec Group, Beijing 100029, China.
  • Yang ZN; China National Biotec Group, Beijing 100029, China.
  • Su JF; China National Biotec Group, Beijing 100029, China.
  • Shu X; China National Biotec Group, Beijing 100029, China.
  • Zhang Y; China National Biotec Group, Beijing 100029, China.
  • Yang XM; China National Biotec Group, Beijing 100029, China National United Vaccine Engineering Technology Research Center, Wuhan 430207, China.
Zhonghua Yu Fang Yi Xue Za Zhi ; 57(1): 100-106, 2023 Jan 06.
Article em Zh | MEDLINE | ID: mdl-36655265
This article reviews the relevant studies on the efficacy and safety of influenza, pneumococcal and COVID-19 vaccination among tumor patients worldwide in recent years. By combing and analyzing the retrieved literature, the results show that influenza and pneumococcal vaccination can significantly reduce the morbidity and hospitalization rate of infectious diseases in tumor patients, reduce the risk of cardiovascular events and death, and significantly improve survival prognosis. COVID-19 vaccination can also protect tumor patients, especially those who have completed full dose vaccination. Authoritative guidelines and consensuses worldwide all recommend that tumor patients receive influenza, pneumococcal and COVID-19 vaccines. We should carry out relevant researches, as well as take effective measures to strengthen patient education, so that tumor patients can fully experience the health protection brought by the vaccine to this specific group.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vacinas contra Influenza / Influenza Humana / COVID-19 / Neoplasias Limite: Humans Idioma: Zh Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vacinas contra Influenza / Influenza Humana / COVID-19 / Neoplasias Limite: Humans Idioma: Zh Ano de publicação: 2023 Tipo de documento: Article